Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Accuracy and Variability of Prostate Multiparametric Magnetic Resonance Imaging Interpretation Using the Prostate Imaging Reporting and Data System: A Blinded Comparison of Radiologists.

Pickersgill NA, Vetter JM, Andriole GL, Shetty AS, Fowler KJ, Mintz AJ, Siegel CL, Kim EH.

Eur Urol Focus. 2018 Oct 13. pii: S2405-4569(18)30301-8. doi: 10.1016/j.euf.2018.10.008. [Epub ahead of print]

PMID:
30327280
2.

Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists.

Sonn GA, Fan RE, Ghanouni P, Wang NN, Brooks JD, Loening AM, Daniel BL, To'o KJ, Thong AE, Leppert JT.

Eur Urol Focus. 2017 Dec 6. pii: S2405-4569(17)30266-3. doi: 10.1016/j.euf.2017.11.010. [Epub ahead of print]

3.

Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?

Hoffmann R, Logan C, O'Callaghan M, Gormly K, Chan K, Foreman D.

Int Urol Nephrol. 2018 Jan;50(1):13-19. doi: 10.1007/s11255-017-1753-1. Epub 2017 Nov 29.

PMID:
29188489
4.

Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.

Mertan FV, Greer MD, Shih JH, George AK, Kongnyuy M, Muthigi A, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

J Urol. 2016 Sep;196(3):690-6. doi: 10.1016/j.juro.2016.04.057. Epub 2016 Apr 18.

PMID:
27101772
5.

Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy.

Hansen NL, Kesch C, Barrett T, Koo B, Radtke JP, Bonekamp D, Schlemmer HP, Warren AY, Wieczorek K, Hohenfellner M, Kastner C, Hadaschik B.

BJU Int. 2017 Nov;120(5):631-638. doi: 10.1111/bju.13711. Epub 2016 Dec 21.

6.

Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.

Radtke JP, Wiesenfarth M, Kesch C, Freitag MT, Alt CD, Celik K, Distler F, Roth W, Wieczorek K, Stock C, Duensing S, Roethke MC, Teber D, Schlemmer HP, Hohenfellner M, Bonekamp D, Hadaschik BA.

Eur Urol. 2017 Dec;72(6):888-896. doi: 10.1016/j.eururo.2017.03.039. Epub 2017 Apr 8.

PMID:
28400169
7.

Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.

Thompson JE, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L, Pulbrook M, Böhm M, Haynes AM, Hayen A, Stricker PD.

J Urol. 2014 Jul;192(1):67-74. doi: 10.1016/j.juro.2014.01.014. Epub 2014 Feb 8.

PMID:
24518762
8.

Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales.

Rosenkrantz AB, Kim S, Lim RP, Hindman N, Deng FM, Babb JS, Taneja SS.

Radiology. 2013 Nov;269(2):482-92. doi: 10.1148/radiol.13122233. Epub 2013 Jun 20.

PMID:
23788719
9.

Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?

Luzzago S, Petralia G, Musi G, Catellani M, Alessi S, Di Trapani E, Mistretta FA, Serino A, Conti A, Pricolo P, Nazzani S, Mirone V, Matei DV, Montanari E, de Cobelli O.

Clin Genitourin Cancer. 2018 Oct 23. pii: S1558-7673(18)30554-8. doi: 10.1016/j.clgc.2018.10.006. [Epub ahead of print]

PMID:
30527286
10.

The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer.

Zhao C, Gao G, Fang D, Li F, Yang X, Wang H, He Q, Wang X.

Clin Imaging. 2016 Sep-Oct;40(5):885-8. doi: 10.1016/j.clinimag.2016.04.010. Epub 2016 Apr 26.

PMID:
27179959
11.

Diagnostic Performance and Interobserver Consistency of the Prostate Imaging Reporting and Data System Version 2: A Study on Six Prostate Radiologists with Different Experiences from Half a Year to 17 Years.

Ke Z, Wang L, Min XD, Feng ZY, Kang Z, Zhang PP, Li BS, You HJ, Hou SC.

Chin Med J (Engl). 2018 Jul 20;131(14):1666-1673. doi: 10.4103/0366-6999.235872.

12.

Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting.

Grey AD, Chana MS, Popert R, Wolfe K, Liyanage SH, Acher PL.

BJU Int. 2015 May;115(5):728-35. doi: 10.1111/bju.12862. Epub 2014 Oct 22.

13.

Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.

Girometti R, Giannarini G, Greco F, Isola M, Cereser L, Como G, Sioletic S, Pizzolitto S, Crestani A, Ficarra V, Zuiani C.

J Magn Reson Imaging. 2018 Sep 5. doi: 10.1002/jmri.26220. [Epub ahead of print]

PMID:
30187600
14.

Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.

Kuhl CK, Bruhn R, Krämer N, Nebelung S, Heidenreich A, Schrading S.

Radiology. 2017 Nov;285(2):493-505. doi: 10.1148/radiol.2017170129. Epub 2017 Jul 20.

PMID:
28727544
15.

Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.

Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J.

Eur Urol. 2018 Jun 13. pii: S0302-2838(18)30424-X. doi: 10.1016/j.eururo.2018.05.035. [Epub ahead of print]

16.

Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.

Radtke JP, Schwab C, Wolf MB, Freitag MT, Alt CD, Kesch C, Popeneciu IV, Huettenbrink C, Gasch C, Klein T, Bonekamp D, Duensing S, Roth W, Schueler S, Stock C, Schlemmer HP, Roethke M, Hohenfellner M, Hadaschik BA.

Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19.

PMID:
26810346
17.

What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.

Borofsky S, George AK, Gaur S, Bernardo M, Greer MD, Mertan FV, Taffel M, Moreno V, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Radiology. 2018 Jan;286(1):186-195. doi: 10.1148/radiol.2017152877. Epub 2017 Oct 20.

PMID:
29053402
18.

Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer.

Hansen NL, Barrett T, Kesch C, Pepdjonovic L, Bonekamp D, O'Sullivan R, Distler F, Warren A, Samel C, Hadaschik B, Grummet J, Kastner C.

BJU Int. 2018 Jul;122(1):40-49. doi: 10.1111/bju.14049. Epub 2017 Nov 15.

PMID:
29024425
19.

Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.

Tewes S, Hueper K, Hartung D, Imkamp F, Herrmann TR, Weidemann J, Renckly S, Kuczyk MA, Wacker F, Peters I.

World J Urol. 2015 Nov;33(11):1707-14. doi: 10.1007/s00345-015-1525-4. Epub 2015 Mar 14.

PMID:
25774003
20.

Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.

Krishna S, McInnes M, Lim C, Lim R, Hakim SW, Flood TA, Schieda N.

AJR Am J Roentgenol. 2017 Dec;209(6):W365-W373. doi: 10.2214/AJR.17.17964. Epub 2017 Oct 5.

PMID:
28981356

Supplemental Content

Support Center